CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «CYTOTOXIN»
Descoperă întrebuințarea
cytotoxin în următoarea selecție bibliografică. Cărți în legătură cu
cytotoxin și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
Bacterial Secreted Proteins: Secretory Mechanisms and Role ...
Upon acid exposure, the cytotoxin undergoes structural changes characterized
by turn to β-structure transition, and neutralisation results in further structural
alterations affecting its proteinase digestion profile (de Bernard et al., 1995).
2
Comprehensive Natural Products II: Chemistry and Biology: 10 ...
Patellin 3 Patellin 4 Patellin 5 Patellin 6 Tawicyclamide A, dehydrotawicyclamide
A Tawicyclamide B, dehydrotawicyclamide B Trunkamide Ulithiacyclamide A
Ulithiacyclamide B,E-G Not reported G2/M block Modest cytotoxin Modest
cytotoxin ...
3
Bacterial Protein Toxins
The cytotoxin, which could be purified more than 5000-fold, showed a molecular
mass of approximately 9()kDa under denaturing conditions, whereas the native
toxin was an aggregate with a molecular mass of approximately lOOOkDa (Cover
...
M. Aepfelbacher, K. Aktories, I. Just, 2000
Recently, cases of CDAC have been attributed to strains producing only toxin B
or undetectable toxin A. Some strains produce no toxin and presumably do not
cause disease. The cytotoxin assay detects toxins capable of causing a
cytopathic ...
Steven D. Wexner, Neil Stollman, 2006
5
Cytotoxins and Immunotoxins for Cancer Therapy: Clinical ...
To target these receptors, we developed a chimeric fusion protein composed of IL
-13 and Pseudomonas exotoxin (IL-13 cytotoxin or IL-13-PE) that specifically
binds to IL-13 receptor positive cells and kills them by inducing apoptosis and ...
Koji Kawakami, Bharat B. Aggarwal, Raj K. Puri, 2004
6
Helicobacter pylori Infection and Immunity: Infection and ...
Journal oJ Biological Chemistry, 267:10570. 65. Garner J. A., and Cover T. L.,
1995, Analysis of genetic diversity in cytotoxin-producing and non-cytotoxin-
productin Hclicobacter pylroi strains. The Journal oJ Infec tmus Diseases, 170:
290. 66.
Yoshimasa Yamamoto, Herman Friedman, Paul S. Hoffman, 2001
7
Helicobacter pylori: Basic Mechanisms to Clinical Cure, 1998 ...
Cytotoxin production by Campylobacter pylori strains isolated from patients with
peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989;
27:225-6. 3. Goosens H, Glupczynski Y, Burette A. Role of the vacuolating toxin ...
Richard H. Hunt, G. N. J. Tytgat, Axcan Pharma, 1998
8
Essentials of Mucosal Immunology
54. of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori
strains. J. Biol. Chem. 269, 10566-10573. Telford, J. L., Ghiara, P., Dell'Orco, M.,
et al. (1994). Gene structure of the Helicobacter pylori cytotoxin and evidence of ...
Martin F. Kagnoff, Hiroshi Kiyono, 1996
9
Inflammatory Bowel Disease
have been reported in patients with positive cytotoxin assays. 6K68 Although
such changes were attributed to "early" features of pseudomembranous colitis,
this clinical presentation might also be considered typical of Crohn's colitis;
indeed, ...
10
Mass Spectrometry of Proteins and Peptides
mol wt (Daltons) Measured Calculated Toxin 6817.3 7534.3 7836.4 7837.0 Long
neurotoxin 1 (40) 7824.2 7823.0 Long neurotoxin 3 (41) 7878.5 7879.0 Long
neurotoxin 4 (41) 6781.6 6783.2 Cytotoxin 1 (42) 6736.8 6737.2 Cytotoxin 3 (43)
...
ȘTIRI NOI CARE INCLUD TERMENUL «CYTOTOXIN»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
cytotoxin în contextul următoarelor știri.
Zacks Rating on Threshold Pharmaceuticals, Inc.
... are designed to specifically target the hypoxic microenvironment of tumors by selective activation of the prodrug to release a potent cytotoxin. «News Watch International, Iul 15»
GenSpera Announces Private Placement of $2.5 Million
GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that ... «MarketWatch, Iul 15»
Company Shares of Threshold Pharmaceuticals, Inc. Drops by -4.35%
... are designed to specifically target the hypoxic microenvironment of tumors by selective activation of the prodrug to release a potent cytotoxin. «News Watch International, Iul 15»
Cantor Fitzgerald Reaffirms "Buy" Rating for Threshold …
Upon activation, TH-302 releases bromo isophosphoramide mustard (NASDAQ:THLD), a potent cytotoxin that kills cells by causing DNA to ... «The Legacy, Iul 15»
Threshold Pharmaceuticals's Buy Rating Reaffirmed at Cantor …
Upon activation, TH-302 releases bromo isophosphoramide mustard (NASDAQ:THLD), a potent cytotoxin that kills cells by causing DNA to ... «Dakota Financial News, Iul 15»
Cantor Fitzgerald Reaffirms Buy Rating for Threshold …
Upon activation, TH-302 releases bromo isophosphoramide mustard (NASDAQ:THLD), a potent cytotoxin that kills cells by causing DNA to ... «sleekmoney, Iul 15»
Analyst Price Target Update on Threshold Pharmaceuticals, Inc.
... are designed to specifically target the hypoxic microenvironment of tumors by selective activation of the prodrug to release a potent cytotoxin. «American Trade Journal, Iul 15»
GenSpera Inc. - "Pricing vs Value of Cancer Drugs"
GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that ... «Baystreet.ca, Iul 15»
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Analyst Rating …
... are designed to specifically target the hypoxic microenvironment of tumors by selective activation of the prodrug to release a potent cytotoxin. «Investor Newswire, Iun 15»
Threshold Pharmaceuticals, Inc. Short Interest Update
... are designed to specifically target the hypoxic microenvironment of tumors by selective activation of the prodrug to release a potent cytotoxin. «American Trade Journal, Iun 15»
